StockScouter

The StockScouter® System is a proprietary stock scoring model which covers U.S. companies listed on the major exchanges. The 10 (best) to 1 (worst) score is derived from Fundamental, Technical, Ownership, and Valuation sub-models in combination with a Risk model which assesses the expected risk and return.

StockScouter Screening Tool StockScouter Top 50

ELOX ELOXX PHARMACEUTICALS INCORPORATED StockScouter® Report

2

StockScouter® Score

ELOXX PHARMACEUTICALS INCORPORATED, a small cap company in the healthcare sector, is expected to underperform the market over the next six months with higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Shares are neither being accumulated heavily nor sold heavily by financial institutions. Neutral for a small company like ELOX

 

Concerns

  • The multi-period measure of relative price change and consistency is well below average. Negative
  • The 50-day moving average for ELOX is significantly below its 200-day moving average. Negative
  • One or more analysts has modestly decreased quarterly earnings estimates for ELOX. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be out of favor, stocks will be , and healthcare stocks will be out of favor.

Expected Risk/Return

Progress: 100% done.
Progress: 20% done.
Low
High

Core Model Grades

D
C
N/A
F

Previous Ratings

2
4
1